YAP1 and ovarian carcinoma: However, it is also possible that additional mechanisms might be engaged in CK2α-promoted ovarian cancer progression as the reconstitution of YAP1 could not completely restored phenotypical changes caused by targeting CK2α in ovarian cancer cells (Fig. 1E–L, Fig. S2C–N).